Data Extraction

(i) March, the EIB dedicated EUR 10 billion in asset-backed securities (ABS) purchasing programs to allow banks to transfer risk on portfolios of SME loans; (ii) 9 April, EU finance ministers decided to establish Pandemic Crisis Support credit lines within the framework of the European Stability Mechanism (ESM). Access granted will be 2% of the respective country's GDP as of end-2019, as a benchmark (about EUR 240 billion in total). The credit line will be available until the COVID-19 crisis is over. The only requirement to access the credit line is that euro area Member States requesting support would commit to use this credit line to finance direct and indirect healthcare, cure and prevention related costs due to the COVID 19 crisis. On May 15, the Board of Governors of the ESM approved the establishment of Pandemic Crisis Support ; (iii) No amount/estimate: European Green Deal investments will remain a priority as part of the EU's efforts to kickstart its economy post-crisis. One of the three sources of funds for this initiative is a public sector loan facility with the European Investment Bank backed by the EU budget to mobilise between EUR25 and EUR30 billion of investments. For investments in, for instance, district heating networks and renovation of buildings; (iv) April 24, Approved EUR 5 billion in new financing for businesses affected by the coronavirus, and for the development of medica ltechnology. EUR3 billion was dedicated to businesses in Spain and Italy. The approval represents an extension of the loan package first identified on March 16, 2020.

(i) April 8, The Commission is launching ESCALAR, a new investment approach, developed together with the European Investment Fund (EIF), that will support venture capital and growth financing for promising companies. In its pilot phase, ESCALAR will provide up to EUR300 million backed by the European Fund for Strategic Investments (EFSI); (ii) April 24, EIB also approved an equity investment worth EUR75 million for the German company Curevac, through the EIB's Infectious Disease Financing Facility; (iii) June 8, EUR174 million equity investments from the European Innovation Council (EIC) Accelerator Pilot funding to innovative startups and SMEs.

(i) March, the EIB dedicated EUR 10 billion in asset-backed securities (ABS) purchasing programs to allow banks to transfer risk on portfolios of SME loans; (ii) 9 April, EU finance ministers decided to establish Pandemic Crisis Support credit lines within the framework of the European Stability Mechanism (ESM). Access granted will be 2% of the respective country's GDP as of end-2019, as a benchmark (about EUR 240 billion in total). The credit line will be available until the COVID-19 crisis is over. The only requirement to access the credit line is that euro area Member States requesting support would commit to use this credit line to finance direct and indirect healthcare, cure and prevention related costs due to the COVID 19 crisis. On May 15, the Board of Governors of the ESM approved the establishment of Pandemic Crisis Support ; (iii) No amount/estimate: European Green Deal investments will remain a priority as part of the EU's efforts to kickstart its economy post-crisis. One of the three sources of funds for this initiative is a public sector loan facility with the European Investment Bank backed by the EU budget to mobilise between EUR25 and EUR30 billion of investments. For investments in, for instance, district heating networks and renovation of buildings; (iv) April 24, Approved EUR 5 billion in new financing for businesses affected by the coronavirus, and for the development of medica ltechnology. EUR3 billion was dedicated to businesses in Spain and Italy. The approval represents an extension of the loan package first identified on March 16, 2020.

(i) April 8, The Commission is launching ESCALAR, a new investment approach, developed together with the European Investment Fund (EIF), that will support venture capital and growth financing for promising companies. In its pilot phase, ESCALAR will provide up to EUR300 million backed by the European Fund for Strategic Investments (EFSI); (ii) April 24, EIB also approved an equity investment worth EUR75 million for the German company Curevac, through the EIB's Infectious Disease Financing Facility; (iii) June 8, EUR174 million equity investments from the European Innovation Council (EIC) Accelerator Pilot funding to innovative startups and SMEs [update].

(i) March, the EIB dedicated EUR 10 billion in asset-backed securities (ABS) purchasing programs to allow banks to transfer risk on portfolios of SME loans; (ii) 9 April, EU finance ministers decided to establish Pandemic Crisis Support credit lines within the framework of the European Stability Mechanism (ESM). Access granted will be 2% of the respective country's GDP as of end-2019, as a benchmark (about EUR 240 billion in total). The credit line will be available until the COVID-19 crisis is over. The only requirement to access the credit line is that euro area Member States requesting support would commit to use this credit line to finance direct and indirect healthcare, cure and prevention related costs due to the COVID 19 crisis; (iii) No amount/estimate: European Green Deal investments will remain a priority as part of the EU's efforts to kickstart its economy post-crisis. One of the three sources of funds for this initiative is a public sector loan facility with the European Investment Bank backed by the EU budget to mobilise between EUR25 and EUR30 billion of investments. For investments in, for instance, district heating networks and renovation of buildings; (iv) April 24, Approved EUR 5 billion in new financing for businesses affected by the coronavirus, and for the development of medical technology. EUR 3 billion was dedicated to businesses in Spain and Italy. The approval represents an extension of the loan package first identified on March 16, 2020.

(i) April 8, The Commission is launching ESCALAR, a new investment approach, developed together with the European Investment Fund (EIF), that will support venture capital and growth financing for promising companies. In its pilot phase, ESCALAR will provide up to EUR300 million backed by the European Fund for Strategic Investments (EFSI); (ii) April 24, EIB also approved an equity investment worth EUR75 million for the German company Curevac, through the EIB's Infectious Disease Financing Facility [update].

(i) March, the EIB dedicated EUR 10 billion in asset-backed securities (ABS) purchasing programs to allow banks to transfer risk on portfolios of SME loans; (ii) 9 April, EU finance ministers decided to establish Pandemic Crisis Support credit lines within the framework of the European Stability Mechanism (ESM). Access granted will be 2% of the respective country's GDP as of end-2019, as a benchmark (about EUR 240 billion in total). The credit line will be available until the COVID-19 crisis is over. The only requirement to access the credit line is that euro area Member States requesting support would commit to use this credit line to finance direct and indirect healthcare, cure and prevention related costs due to the COVID-19 crisis; (iii) No amount/estimate: European Green Deal investments will remain a priority as part of the EU's efforts to kickstart its economy post-crisis. One of the three sources of funds for this initiative is a public sector loan facility with the European Investment Bank backed by the EU budget to mobilise between EUR25 and EUR30 billion of investments. For investments in, for instance, district heating networks and renovation of buildings.

April 8, The Commission is launching ESCALAR, a new investment approach, developed together with the European Investment Fund (EIF), that will support venture capital and growth financing for promising companies. In its pilot phase, ESCALAR will provide up to EUR300 million backed by the European Fund for Strategic Investments (EFSI).